Non-interventional Pilot Study Evaluating the Efficacy and Safety of Lysozymebased Therapy in Patients with Non-infectious Sore Throat

Acta Med Acad. 2022 Apr;51(1):1-13. doi: 10.5644/ama2006-124.364.

Abstract

Objective: This study aimed to evaluate the efficacy and safety of lysozyme-based oral antiseptic in the therapy of non-infectious sore throat in teachers.

Materials and methods: A non-interventional, prospective, pilot study was conducted with two examinations. The first was performed as part of a general medical examination. If a non-infectious sore throat was confirmed by clinical checkup and all other inclusion and non-exclusion criteria confirmed, patients were offered to be enrolled in the study. After signing the informed consent form, patients were advised to use lysozyme-based lozenges, six times a day, for a period of five days. A telephone call follow-up examination was performed within 24 hours from the therapy completion.

Results: This was a pilot study involving 25 adult patients of both genders. Lysozyme-based lozenges showed positive effects in relieving the symptoms of non-infectious sore throat in teachers. At the same time, the lozenges showed excellent tolerability, and no side effects were reported during the study. 92% of patients confirmed they would take the same medicine again due to the same problem.

Conclusion: The results of this "proof-of-concept" study indicated that lysozyme-based antiseptic could be effective and safe in the treatment of non-infectious sore throat in teachers and should be further evaluated as treatment option in this condition.

Keywords: Functional Dysphonia; Lysozyme; Professional Exposure; Sore Throat.

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-Infective Agents, Local*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Muramidase / therapeutic use
  • Pharyngitis* / drug therapy
  • Pilot Projects
  • Prospective Studies

Substances

  • Anti-Infective Agents, Local
  • Muramidase